vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and GENESCO INC (GCO). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $616.2M, roughly 1.3× GENESCO INC). GENESCO INC runs the higher net margin — 0.9% vs 0.5%, a 0.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 3.3%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -8.7%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Genesco Inc. is an American publicly owned specialty retailer of branded footwear and accessories and is a wholesaler of branded and licensed footwear based in Nashville, Tennessee. Founded back in 1924 as Jarman Shoe Company, a footwear manufacturer, the company changed its name to General Shoe Corporation in 1933, and became a public company in 1939. By 1957, its stock would be included in the first S&P 500 Index. The company took its current name, Genesco—an acronym derived from its earlie...
ACHC vs GCO — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $616.2M |
| Net Profit | $4.5M | $5.4M |
| Gross Margin | — | 46.8% |
| Operating Margin | — | 1.4% |
| Net Margin | 0.5% | 0.9% |
| Revenue YoY | 7.5% | 3.3% |
| Net Profit YoY | -50.8% | 128.3% |
| EPS (diluted) | $0.05 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $616.2M | ||
| Q3 25 | $851.6M | $546.0M | ||
| Q2 25 | $869.2M | $474.0M | ||
| Q1 25 | $770.5M | $745.9M | ||
| Q4 24 | $774.2M | $596.3M | ||
| Q3 24 | $815.6M | $525.2M | ||
| Q2 24 | $796.0M | $457.6M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $5.4M | ||
| Q3 25 | $36.2M | $-18.5M | ||
| Q2 25 | $30.1M | $-21.2M | ||
| Q1 25 | $8.4M | $34.4M | ||
| Q4 24 | $32.6M | $-18.9M | ||
| Q3 24 | $68.1M | $-10.0M | ||
| Q2 24 | $78.5M | $-24.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 46.8% | ||
| Q3 25 | — | 45.8% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.9% | ||
| Q4 24 | — | 47.8% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 47.3% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 1.4% | ||
| Q3 25 | 4.7% | -2.6% | ||
| Q2 25 | 5.8% | -5.9% | ||
| Q1 25 | 1.7% | 6.2% | ||
| Q4 24 | 4.9% | 1.7% | ||
| Q3 24 | 12.1% | -2.0% | ||
| Q2 24 | 13.4% | -7.0% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 0.9% | ||
| Q3 25 | 4.3% | -3.4% | ||
| Q2 25 | 3.5% | -4.5% | ||
| Q1 25 | 1.1% | 4.6% | ||
| Q4 24 | 4.2% | -3.2% | ||
| Q3 24 | 8.4% | -1.9% | ||
| Q2 24 | 9.9% | -5.3% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.50 | ||
| Q3 25 | $0.40 | $-1.79 | ||
| Q2 25 | $0.33 | $-2.02 | ||
| Q1 25 | $0.09 | $3.16 | ||
| Q4 24 | $0.36 | $-1.76 | ||
| Q3 24 | $0.74 | $-0.91 | ||
| Q2 24 | $0.85 | $-2.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $27.0M |
| Total DebtLower is stronger | $2.5B | $89.5M |
| Stockholders' EquityBook value | $2.0B | $513.8M |
| Total Assets | $5.5B | $1.5B |
| Debt / EquityLower = less leverage | 1.29× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $27.0M | ||
| Q3 25 | $118.7M | $41.0M | ||
| Q2 25 | $131.4M | $21.7M | ||
| Q1 25 | $91.2M | $34.0M | ||
| Q4 24 | $76.3M | $33.6M | ||
| Q3 24 | $82.1M | $45.9M | ||
| Q2 24 | $77.2M | $19.2M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $89.5M | ||
| Q3 25 | $2.3B | $71.0M | ||
| Q2 25 | $2.3B | $121.0M | ||
| Q1 25 | $2.2B | $0 | ||
| Q4 24 | $2.0B | $100.1M | ||
| Q3 24 | $1.9B | $77.8M | ||
| Q2 24 | $1.8B | $59.4M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $513.8M | ||
| Q3 25 | $3.1B | $506.4M | ||
| Q2 25 | $3.1B | $522.2M | ||
| Q1 25 | $3.0B | $547.0M | ||
| Q4 24 | $3.1B | $516.9M | ||
| Q3 24 | $3.0B | $532.6M | ||
| Q2 24 | $3.0B | $548.5M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $1.5B | ||
| Q3 25 | $6.4B | $1.4B | ||
| Q2 25 | $6.3B | $1.4B | ||
| Q1 25 | $6.1B | $1.3B | ||
| Q4 24 | $6.0B | $1.4B | ||
| Q3 24 | $5.9B | $1.4B | ||
| Q2 24 | $5.7B | $1.3B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.17× | ||
| Q3 25 | 0.74× | 0.14× | ||
| Q2 25 | 0.74× | 0.23× | ||
| Q1 25 | 0.72× | 0.00× | ||
| Q4 24 | 0.64× | 0.19× | ||
| Q3 24 | 0.62× | 0.15× | ||
| Q2 24 | 0.62× | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $-12.9M |
| Free Cash FlowOCF − Capex | — | $-31.5M |
| FCF MarginFCF / Revenue | — | -5.1% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | 13.78× | -2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-12.9M | ||
| Q3 25 | $73.2M | $86.3M | ||
| Q2 25 | $133.5M | $-101.0M | ||
| Q1 25 | $11.5M | $117.0M | ||
| Q4 24 | $116.7M | $-23.1M | ||
| Q3 24 | $163.1M | $27.7M | ||
| Q2 24 | $171.1M | $-33.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-31.5M | ||
| Q3 25 | $-63.0M | $71.7M | ||
| Q2 25 | $-34.2M | $-119.9M | ||
| Q1 25 | $-163.2M | $103.3M | ||
| Q4 24 | $-86.8M | $-36.2M | ||
| Q3 24 | $-27.1M | $19.8M | ||
| Q2 24 | $16.9M | $-40.1M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -5.1% | ||
| Q3 25 | -7.4% | 13.1% | ||
| Q2 25 | -3.9% | -25.3% | ||
| Q1 25 | -21.2% | 13.8% | ||
| Q4 24 | -11.2% | -6.1% | ||
| Q3 24 | -3.3% | 3.8% | ||
| Q2 24 | 2.1% | -8.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.0% | ||
| Q3 25 | 16.0% | 2.7% | ||
| Q2 25 | 19.3% | 4.0% | ||
| Q1 25 | 22.7% | 1.8% | ||
| Q4 24 | 26.3% | 2.2% | ||
| Q3 24 | 23.3% | 1.5% | ||
| Q2 24 | 19.4% | 1.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -2.41× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 3.40× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
GCO
| Journeys Group Segment | $376.7M | 61% |
| Schuh Group Segment | $123.8M | 20% |
| Johnston And Murphy Group Segment | $81.2M | 13% |
| Genesco Brands Segment | $34.6M | 6% |
| Store Restructuring | $3.9M | 1% |
